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Background: Rotaviruses are the single most important cause of severe diarrhea in young children worldwide. The
developments of specific, potent and accessible antiviral treatments that restrain rotavirus infection remain
important to control rotavirus disease.
Methods: 150 plant extracts with nutritional applications were screened in vitro on MA-104 cells for their antiviral
activity against rhesus rotavirus (RRV). One extract (Aspalathus linearis (Burm.f.) R.Dahlgren) was also tested for its
effect on the loss of transepithelial resistance (TER) of Caco-2 cells caused by simian rotavirus (SA-11) infection.
Results: Aqueous extracts of Nelumbo nucifera Gaertn. fruit, Urtica dioica L. root, Aspalathus linearis (Burm.f.) R.
Dahlgren leaves, Glycyrrhiza glabra L. root and Olea europaea L. leaves were found to have strong significant
antiviral activity with a 50% inhibitory concentration (IC50)< 300 μg/ml. The pure compound 18ß-glycyrrhetinic
acid from Glycyrrhiza glabra was found to have the strongest antiviral activity (IC50 46 μM), followed by luteolin and
vitexin from Aspalathus linearis (IC50 respectively 116 μM and 129 μM) and apigenin-7-O-glucoside from Melissa
officinalis (IC50 150 μM). A combination of Glycyrrhiza glabra L. + Nelumbo nucifera Gaertn. and Urtica dioica L. +
Nelumbo nucifera Gaertn. showed synergy in their anti-viral activities. Aspalathus linearis (Burm.f.) R.Dahlgren showed
no positive effect on the maintenance of the TER.
Conclusions: These results indicate that nutritional intervention with extracts of Nelumbo nucifera Gaertn.,
Aspalathus linearis (Burm.f.) R.Dahlgren, Urtica dioica L., Glycyrrhiza glabra L. and Olea europaea L. might be useful in
the treatment of diarrhea caused by rotavirus infection.
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Rotavirus is still one of the leading causes of severe de-
hydrating diarrhea in children under the age of five and
causes the deaths of 453,000 children younger than
5 years annually [1]. Rotaviruses, belonging to a genus of
double-stranded RNA viruses in the family Reoviridae,
infect the mature villous epithelial cells of the small in-
testine, often leading to fever, vomiting, and diarrhea in
children. For the treatment of rotavirus gastroenteritis,
intravenous fluid administration has been used success-
fully in treating only the direct consequences of the de-
hydration from diarrhea. Gastrogard-RW is a prophylactic* Correspondence: karen.knipping@danone.com
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reproduction in any medium, provided the ortreatment of ‘at risk’ children aged one month to three
years to prevent diarrhea due to rotavirus infection and
the efficacy of treatment was established in a clinical trial
in children aged 3 to 15 months [2]. Gastrogard-RW is pre-
pared from the colostrum of hyperimmunised cows and
contains immunoglobulins against serotypes G1 and G3
of the human rotavirus. We have demonstrated in an
in vivo rotavirus infection mouse model that Gastrogard-
RW is able to completely inhibit rotavirus-induced diarrhea
in suckling mice [3]. A first generation of licensed rota-
virus vaccine was withdrawn from the market a year after
introduction due to a possible correlation between vaccine
application and the occurrence of intussusceptions [4].
Two live-attenuated vaccines have been licensed recently
and have so far proven safe and highly efficacious in devel-
oped countries. In developing countries, clinical trials are
being undertaken and early results found that the vaccineal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Knipping et al. Virology Journal 2012, 9:137 Page 2 of 8
http://www.virologyj.com/content/9/1/137significantly reduces severe diarrhea episodes due to rota-
virus (48.3% for Asia and 30.2% for Africa) [5]. However,
rotavirus vaccines are expensive and may not be affordable
for the developing world at present, compromising full
vaccine coverage. This has reinforced the need to develop
alternative approaches to control rotavirus disease. Nat-
ural compounds have been identified as ideal candidates
for antiviral drugs because they are cheaper and effective
[6]. To date, many natural compounds have known antiro-
tavirus effects in clinical studies [7-9], in animal experi-
ments [10] and in vitro [11-14]. In the current study we
investigated 150 edible plant extracts and some of their
natural compounds for in vitro anti-rotavirus infection
effects.
MA104 cells is an established cell line for rotavirus
infections studies on which rotavirus receptors have
been identified on the cells [15]. Trypsin usually is added
during infection of MA104 cells with rotavirus to in-
crease the infectivity [16-18]. Intestinal epithelial perme-
ability studies are often performed with human Caco-2
cells [19]. These cells develop polarization of distinct ap-
ical and basolateral surfaces separated by tight junctions
at areas of cell-to-cell contact closely resembling the
physiological situation in the intestine. The transepithe-
lial resistance (TER) is a measure for the tightness of the
tight junctions formed by Caco-2 cells. Rotaviruses are
known to infect epithelial cells of the small intestine and
in vitro rotavirus infection of Caco-2 cells caused disrup-
tion of tight junctions and loss of TER in the absence of
cell death [20]. To investigate whether the loss of TER
could be prevented, Caco-2 cells were infected with SA-
11 rotavirus in the presence of hyperimmune colostrum
(Gastrogard-RW), plant extracts or pure compounds.
From both models, the results of 150 aqueous plant
extracts on their antiviral action against rotavirus are
presented in a search for novel agents for the treatment
of human diarrhea caused by rotavirus infection.
Material and methods
Cells and viruses
MA104 cells (African green monkey kidney cells;
ECACC, Salisbury, UK 85102918) and Caco-2 cells
(Human Caucasian colon adenocarcinoma; ECACC)
were maintained in Eagle’s minimal essential medium
(MEM; Life Technologies, Breda, The Netherlands) sup-
plemented with 10% fetal calf serum (FCS; Greiner Bio-
one, Alphen a/d Rijn, The Netherlands), 2 mM Sodium
pyruvate (Life Technologies) and 1% non-essential
amino acids (Life Technologies). The viruses selected for
this study were the simian rotavirus SA-11 strain
(ATCC) and the rhesus rotavirus (RRV) strain, kindly
provided by Dr. Richard Ward, Cincinnati Children's
Hospital Medical Center, USA. The viruses were grown
in MA104 cells and concentrated by ultracentrifugation.The titers were determined using a titration assay in
MA104 cells resulting in a 50% cell culture infective
dose (CCID50) of 1x108 of both SA-11 and RRV.Hyperimmune colostrum (Gastrogard-RW), plant extracts
and pure compounds
Hyperimmune colostrum (HIC) (Gastrogard-RW, Nutricia,
Adelaide, Australia) was tested in the titration assay on
MA104 cells in the concentrations of 1-2-5-10-50-
100 μg/ml medium and in the transepithelial resistance
measurement in the concentrations of 50 and 100 μg/ml
medium. 150 Plant extracts with known nutritional applica-
tions were selected from an ‘in house’ herbal extract collec-
tion (purchased from PhytoMyco Research Pvt. Ltd.,
Mysore District, Karnataka State, India) consisting of
10,000 herbal extracts. In a set-up for high throughput
screening, all plant extracts were tested as a first screening
in an antiviral titration assay with MA104 cells in the con-
centrations of 400 and 500 μg/ml in medium. When an in-
hibition of infection was determined (<20% inhibition), a
50% inhibitory concentration (IC50) value was calculated.
Extracts that reduced the rotavirus infection were studied
further in two concentrations close to the calculated IC50.
Extracts unable to inhibit the infection were appointed an
arbitrary IC50 of 1000 μg/ml. A complete list of tested
herbal extracts is listed in Additional file 1. Synergy be-
tween two plant extracts was investigated in the titration
assay by assaying the separate compounds as well as
combinations hereof on the same plate. The separate com-
pounds were tested in the calculated IC50 concentration
whereas the combination a mixture was of the IC25
concentration of both extracts. 18ß-glycyrrhetinic acid
(Sigma-Aldrich, St. Louis, USA) was tested in the concen-
trations of 10-20-30-40-50-100 μM in medium. Luteolin,
vitexin and apigenin-7-O-glucoside (Indofine Chemical
Company, Hillsborough, USA) were tested in the con-
centrations of 50 and 100 μM in medium. A complete
list of tested compounds is listed in Additional file 2.Antiviral titration assay
Confluent MA104 cells in a 96-wells plate were first
incubated with various concentrations of the plant ex-
tract and then a two-fold titration range of RRV, starting
at 1*106 CCID50, was added in the presence of 0.5 mg
trypsin/ml (Life Technologies). One well with MA104
cells was incubated with the highest concentration of
the extract as a control. Infection of MA104 cells with
rotavirus induces syncytium after 3-4 days, which is vis-
ible through microscopy. A titration of RRV on MA104
was used as a measure of maximum infection and the
sum of infected wells was considered 100% infection. In-
hibition of the plant extract was calculated against the
maximum infection. Maximum of infection and each
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duplicate.
Transepithelial resistance (TER) measurement
The TER is a measure for the tightness of the tight junc-
tions formed by Caco-2 cells. One electrode of the epi-
thelial volt-ohm meter (World Precision Instuments,
Sarasota, USA) was placed into the apical compartment
of a transwell system (Corning Life Sciences, New Jersey,
USA) and the other into the basolateral compartment.
The electrical resistance is then measured across the cell
monolayer after the passage of a defined current pulse.
Experiments were carried out at two weeks post con-
fluency with fully differentiated cells. One day before in-
fection, the Caco-2 cells were cultured in medium
without FCS. Prior to infection, the SA-11 rotavirus in-
oculum was activated for 20 min by treatment with
0.5 mg trypsin/ml (Invitrogen). The Caco-2 cells were
apically infected with an inoculum of activated rotavirus
(1*106 CCID50) in the presence of the extract and incu-
bated at 37°C and 5% CO2. The integrity of the conflu-
ent polarized monolayer was checked by measuring TER
with a volt-ohmmeter. TER (in units of ohm times centi-
meters squared) was calculated as the measured elec-
trical resistance times the surface area of a filter. The
background reading of a control filter was measured in
every experiment. Infections were carried out in tripli-
cates and all measurements were done at various time
points post infection. The permeability of Caco-2 cell
monolayer was also determined by measuring the para-
cellular passage of HRP or FITC-dextran from apical to
the basolateral compartments of the culture chamber.
The concentrations of FITC-dextran were determined by
measuring the fluorescence at λexcitation 485 nm and
λemission 520 nm. The concentration of HRP was deter-
mined by incubating 50 μl of the sample with 50 μl
TMB for 10 min at RT. The reaction was stopped with
50 μl H2SO4 and the absorbance measured at 450 nm.
Analysis
The 50% cell culture infective dose (CCID50) of SA-11
and RRV were calculated according the Reed and
Muench statistical method [21]. 50% inhibitory concen-
tration (IC50) values were determined by calculating a
statistically validated non-linear regression curve through
the plotted acquired values. X-values (i.e. dosage)
corresponding to the maximal y-value divided by 2, are




The hyperimmune colostrum (HIC) is used as a positive
control and therefore tested in the antiviral titrationassay with MA104 cells in several concentrations
(Figure 1A). The concentration of 1 μg/ml showed an
inhibition of infection with 50% compared to the max-
imum infection with RRV.
The effect of two rotavirus strains on the transepithelial
resistance (TER) with Caco-2 cells was first determined.
Only the SA-11 rotavirus strain, and not RRV, showed a de-
crease in TER. An infection of SA-11 resulted also in a pro-
gressive increase in the paracellular permeability to HRP
(a 40 kD molecule) and FITC-dextran (a 4 kD molecule) in
correlation to the time post infection (data not shown). The
decline in TER of Caco-2 cells by SA-11 and the effect of
the HIC (100 μg/ml) on the TER during SA-11 infection is
depicted in Figure 1B. Infection of Caco-2 cells with SA-11
results in a decline of the TER for more than 80%. Infection
in the presence of HIC showed a complete maintenance of
the TER, comparable to non-infected Caco-2 cells in the
presence of HIC.
Screening of plant extracts
A study of 150 edible plant extracts dissolved in medium
was performed to investigate their inhibitory effects on
rotavirus infection of MA104 cells (Figure 2). Eleven
extracts were able to inhibit the rotavirus infection with a
50% inhibitory concentration (IC50) <300 μg/ml. Among
these 11 extracts were 3 different Urtica dioica L., 2 differ-
ent Nelumbo nucifera Gaertn., 3 different Aspalathus line-
aris (Burm.f.) R.Dahlgren, 2 different Glycyrrhiza glabra L.
extracts and one Olea europeae L. extract. The most po-
tent extract of each plant together with eleven moderate
(IC50 between 300 and 550 μg/ml) inhibitors of rotavirus
infection are depicted in Figure 3. Aspalathus linearis
(Burm.f.) R.Dahlgren has also been tested for its effect on
the TER (100 and 200 μg/ml), but no positive effect on the
maintenance of the TER was measured.
Screening of pure compounds
Twenty-four pure compounds, known to be present in
the strong and moderate inhibitory plant extracts, have
been tested in the antiviral titration assay in the concen-
trations of 50 and 100 μM. Only four compounds
showed an inhibitory effect, 18ß-glycyrrhetinic acid from
Glycyrrhiza glabra was found to have the strongest anti-
viral activity (IC50 46 μM), followed by luteolin and
vitexin from Aspalathus linearis (IC50 respectively
116 μM and 129 μM) and apigenin-7-O-glucoside from
Melissa officinalis (IC50 150 μM). 18ß-glycyrrhetinic has
also been tested for its effect on the TER (25-30-40-
50 μg/ml), but no positive effect on the maintenance of
the TER was measured.
Synergy between plant extracts
Synergism is the phenomenon in which the combined
action of two or more extracts is greater than the sum of
Figure 1 A Inhibitory potential of hyperimmune colostrum (HIC) (Gastrogard-RW) on RRV infection of MA104 cells. Maximum infection
with RRV was set to 100% and the inhibition of HIC in the concentrations 1-2-5-10-50-100 μg/ml was calculated as a percentage against
maximum infection. Bars represent average of triplicate values + SD. B Maintenance of transepithelial resistance (TER) ± SD of Caco-2 cells by HIC
after infection with SA-11 rotavirus. The black line shows the decline in relative resistance in time caused by the SA-11 rotavirus infection. The
light grey line depicts the cell control with no infection but in the presence of HIC (100 μg/ml). The dark grey line depicts infection of Caco-2
cells with SA-11 in the presence of HIC (100 μg/ml).
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of plant extracts showed synergy and are depicted in Fig-
ure 4. Glycyrrhiza glabra L. (250 μg/ml) inhibited infec-
tion with 67% and Nelumbo nucifera Gaertn. (150 μg/
ml) with 52%, whereas a combination of the IC25 (Gly-
cyrrhiza 125 μg/ml and Nelumbo 75 μg/ml) showed an
inhibition of 89%. This is also seen with a combination
of Urtica dioica L. and Nelumbo nucifera Gaertn. Urtica
dioica L. (230 μg/ml) inhibited infection with 57% and
Nelumbo nucifera Gaertn. (150 μg/ml) with 52%. The
combination of Urtica 115 μg/ml and Nelumbo 75 μg/
ml showed an inhibition of 86% of the infection.
Discussion
Recently, there is a growing interest in the interaction
between pharmacology and nutrition science. Pharma-
ceuticals are generally developed to treat, cure or pre-
vent disease and the primary goal of nutrition is toFigure 2 Of 150 plant extracts (black dots), 11 extracts strongly inhib
concentration (IC50) <300 μg/ml (below the black dashed line).maintain or even improve health. This does not imply
that there is no role for nutrition in preventing or curing
disease [22]. The 150 plant extracts used in the screen-
ing here were selected because of their known nutri-
tional uses. The nutritional applications and antiviral
activities of the five strongest rotavirus inhibitors are dis-
cussed. Nelumbo nucifera (sacred water lotus) is not a
well known food ingredient in Europe, but in Asia the
roots are often eaten as a vegetable in soups, deep-fried,
stir-fried and braised dishes. Nelumbo nucifera is known
to have antiviral action against HIV [23] and Herpes
simplex virus (HSV) [24]. Aspalathus linearis leaves are
used to make redbush tea which has been popular in
Southern Africa for generations and is now consumed in
many countries. No antiviral activity has been reported
yet for Aspalathus linearis. Urtica dioica (stinging net-
tle) can be used in a variety of recipes and nettle soup is
a common use of the plant, particularly in Northern andited the rotavirus infection of MA104 cells with a 50% inhibitory
Figure 3 Five strong (IC50 <300 μg/ml) and eleven moderate (IC50 between 300 and 550 μg/ml) inhibitory plant extract. Bars represent
average of duplicate analysis + SD.
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popular vegetable and cooked with Indian spices. Known
antiviral actions of Urtica dioica are inhibition of both
HIV and FIV, the feline variant of HIV [25,26].Figure 4 Synergism in antiviral activity in the combinations Glycyrrhiz
Nelumbo nucifera Gaertn. B. The separate extracts were tested in their IC
of the extracts. Inhibition was calculated against the control viral infectionGlycyrrhiza glabra is also known as European licorice
and the root extract is used as flavoring in sweets, baked
goods, ice cream and soft drinks. Only one other mem-
ber of the Glycyrrhiza sp., Glycyrrhiza uralensis (Chinesea glabra L. + Nelumbo nucifera Gaertn. A and Urtica dioica L. +
50 concentration, combinations were made of the IC25 concentration
(RRV; 100%). Bars represent average of triplicate values + SD.
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viral activity against rotavirus [27]. Glycyrrhiza glabra it-
self is known to have inhibitory activity against several
unrelated DNA and RNA viruses [28-30]. Olea europeae
fruit (olive) is of major agricultural importance in the
Mediterranean region as the source of olive oil. Olea
europeae exhibits antiviral activity against viral haemor-
rhagic septicaemia rhabdovirus (VHSV) [31]. For these
nutritional ingredients we have demonstrated antirota-
virus activity in vitro. This illustrates the potential for
the use of specific plant extracts for treatment or pre-
vention of rotavirus illness.
Twenty-four pure compounds, known to be present in
the strong and moderate rotavirus inhibitory plant
extracts, have been tested in the antiviral titration assay,
but only 4 compounds showed antiviral activity. 18ß-
glycyrrhetinic acid, a constituent of Glycyrrhiza glabra,
was the strongest inhibitor. Glycyrrhizic acid is one of
the bioactive compounds of licorice roots and is com-
posed of one molecule of 18ß-glycyrrhetinic acid, which
has a steroid-like structure, and two molecules of glu-
curonic acid. Lin et al. reported 18ß-glycyrrhetinic acid
to have a stronger action against Epstein-Barr virus than
its parental compound glycyrrhizic acid [32]. Two con-
stituents of Aspalathus linearis, luteolin and vitexin, also
showed antiviral activity against rotavirus in the antiviral
titration assay. Luteolin is a flavonoid most often found
in leaves and vitexin is an apigenin flavone glucoside.
Both compounds are found in many different plant spe-
cies other than Aspalathus. The weakest inhibitor was
apigenin 7-O-glucoside, also a flavonoid and can be
found in for example lemon balm (Melissa officinalis),
chamomile (Chamomilla recutita) and celery (Apium
graveolens). So far as we know this is the first study
showing that luteolin, vitexin and apigenin 7-O-
glucoside have antiviral activity in vitro. Although the
mechanism of action has yet to be defined, this is a first
step in a potential wider, more pharmacological use of
these nutritional ingredients. The possibility that there
are other active compounds present in the positive plant
extracts has to be further investigated. The positive con-
trol hyperimmune colostrum (HIC) showed inhibitory
action against rotavirus infection in both the antiviral ti-
tration assay with RRV in MA104 cells as well as in
maintaining the TER in Caco-2 cells infected with SA-11.
In synergism studies, where the extracts have been com-
bined in the IC25 concentration, synergism in antiviral
activity was found in the combinations Glycyrrhiza
glabra L. + Nelumbo nucifera Gaertn. and Urtica dioica
L. + Nelumbo nucifera Gaertn. The separate extracts with
IC50 concentration showed an inhibition of infection of
about 50%. Both combinations in the IC25 concentra-
tion of the extracts showed an inhibition of more than
50%, respectively 89% and 86%. This indicates thatthe extracts in the combination have different antiviral
actions. This illustrates the importance for further re-
search into the mechanism of action of the individual
ingredients, as well as in vivo validation of the anti-
viral capacity.
The level of antiviral activity as tested in vitro can only
be used as an indication for the therapeutical benefit of
the component in vivo. Within this study, the aspects
related to toxicity, taste, stability, availability, duration of
supplementation, regulation, drug interactions and phar-
macokinetic profile were not taken into account. There-
fore, no statements can currently be made regarding the
in vivo applicability of any of these nutritional com-
pounds. However, since most herbs are currently used as
nutritional ingredients and rotavirus is an intestinal
pathogen, there is clear potential for the interventions as
described.
Within several studies, natural extracts were tested for
their antiviral capacity [11,33,34]. Although the isolated
active compounds have shown antiviral activities with
IC50 values ranging from 0.1 mg/ml – 250 mg/ml, the
crude extract most of the times only reached an antiviral
activity IC50 was not below 30 mg/ml. Therefore a
crude extract reaching the IC50 of <0.3 mg/ml was
regarded as a strong inhibitor. Moreover, it is specified
that each extract and active compound has its own bio-
availability and activity in vivo [35]. Therefore additional
research in this field is needed on the potential of use
for these natural compounds single or in combinations
of each other for the use in clinical setting. Comparisons
and screening are therefore a valuable start.
The titration assay using MA104-cells has proven to
be a useful assay to measure the inhibitory ability of
plant extracts on a rotaviral infection. In contrast, as-
sessment of TER did not reveal inhibitory compounds.
In this study only the SA-11 rotavirus strain, and not
RRV, showed a decrease in TER even though previous
published data has shown an effect of RRV on Caco-2
TER [20]. Cho et all. showed that absorption enhancers
like 18ß-glycyrrhetinic acid and taurine can decrease
TER of Caco-2 cells and increase the permeability in a
dose-dependent and time-dependent manner [36]. These
results indicate that absorption enhancers can widen the
tight junction even without rotavirus infection. In future
experiments using TER with extracts, this increase in
permeability without rotavirus infection should be
excluded for each extract.
Conclusions
These data demonstrate for the first time that generally
used nutritional extracts of Nelumbo nucifera Gaertn.,
Aspalathus linearis (Burm.f.) R.Dahlgren, Urtica dioica
L., Glycyrrhiza glabra L. and Olea europaea L. have
in vitro antiviral activity against rotavirus. None of these
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tion against rotaviruses. The antiviral action can even be
enhanced by combining of Glycyrrhiza glabra L.,
Nelumbo nucifera Gaertn. and/or Urtica dioica L.
extracts, indicating different mechanisms of action.
Therefore, combinations of these plants are potentially
useful in the treatment of diarrhea caused by rotavirus.
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